scholarly journals What is it going to be, TTO or SG? A direct test of the validity of health state valuation

2020 ◽  
Vol 29 (11) ◽  
pp. 1475-1481
Author(s):  
Stefan A. Lipman ◽  
Werner B. F. Brouwer ◽  
Arthur E. Attema



2012 ◽  
Vol 22 (4) ◽  
pp. 705-714 ◽  
Author(s):  
Liv A. Augestad ◽  
Kim Rand-Hendriksen ◽  
Knut Stavem ◽  
Ivar Sønbø Kristiansen




2019 ◽  
Vol 7 ◽  
Author(s):  
Eunice Lobo ◽  
Lipika Nanda ◽  
Shuchi Sree Akhouri ◽  
Chandni Shrivastava ◽  
Roshan Ronghang ◽  
...  


2013 ◽  
Vol 16 (6) ◽  
pp. 1091-1099 ◽  
Author(s):  
Sanjeewa Kularatna ◽  
Jennifer A. Whitty ◽  
Newell W. Johnson ◽  
Paul A. Scuffham


2017 ◽  
Vol 19 (6) ◽  
pp. 881-891 ◽  
Author(s):  
John Brazier ◽  
Donna Rowen ◽  
Milad Karimi ◽  
Tessa Peasgood ◽  
Aki Tsuchiya ◽  
...  


Author(s):  
John Brazier ◽  
Julie Ratcliffe ◽  
Joshua A. Salomon ◽  
Aki Tsuchiya

This chapter focuses upon the needs of two approaches, economic evaluations based on decision analytic models, and those alongside clinical trials in terms of the collection and analysis of health state values. The first section of the chapter presents requirements that are likely to be common to any study in which health state values are collected from patients and/or members of the general population, including: who to ask, mode of administration, timing of assessments, sample size, and handling uncertainty. The second section of the chapter considers issues specific to trial-based economic evaluations, and the final section considers issues specific to the design and analysis of health state valuation data for economic models.





1997 ◽  
Vol 45 (11) ◽  
pp. 1641-1652 ◽  
Author(s):  
Paul F.M. Krabbe ◽  
Marie-Louise Essink-Bot ◽  
Gouke J. Bonsel


Sign in / Sign up

Export Citation Format

Share Document